Predictive Factors of Late Venous Aortocoronary Graft Failure: Ultrastructural Studies

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Perek, Bartlomiej ^a   Malinska, Agnieszka ^a   Stefaniak, Sebastian ^a   Ostalska Nowicka, Danuta ^a   Misterski, Marcin ^a   Zabel, Maciej ^a   Suri, Anuj ^a   Nowicki, Michal ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVENTITIA; AGED; ANATOMICAL VARIATION; ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR RISK; CELL ULTRASTRUCTURE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT PATENCY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTIMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RISK ASSESSMENT; RISK FACTOR; SAPHENOUS VEIN GRAFT; SMOOTH MUSCLE FIBER; TUNICA MEDIA; ULTRASTRUCTURE;

EID: 84881106795     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070628     Document Type: Article

References (33)

1. Davis KB, Chaitman B, Ryan T, Bittner V, Kennedy JW, (1995) Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study. Coronary Artery Surgery Study. J Am Coll Cardiol 25: 1000-1009.
2. Epstein AJ, Polsky D, Yang F, Yang L, Groeneveld PW, (2011) Coronary Revascularization Trends in the United States, 2001-2008. JAMA 305: 1769-1776.
3. Halabi AR, Alexander JH, Shaw LK, Lorenz TJ, Liao L, et al. (2005) Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. Am J Cardiol 96: 1254-1259.
4. Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easley K, et al. (1985) Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg 89: 248-258.
5. Cooper GJ, Underwood MJ, Deverall PB, (1996) Arterial and venous conduits for coronary artery bypass. A current review. Eur J Cardio-Thorac Surg 10: 129-140.
6. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, et al. (1996) Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. JACC 28: 616-626.
7. Zacharias A, Habib RH, Schwann TA, Riordan CJ, Durham SJ, et al. (2004) Improved survival with radial artery venous vein conduits in coronary bypass surgery with left internal thoracic artery to left anterior descending artery grafting. Circulation 109: 1489-1496.
8. Klinkert P, Post PN, Breslau PJ, van Bockel JH, (2004) Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 27: 357-362.
9. Motwani JG, Topol EJ, (1998) Aortocoronary saphenous vein graft disease: pathogenesis, predisposition and prevention. Circulation 97: 916-931.
10. Ditchburn CJ, Hall JA, de Belder M, Davies A, Kelly W, et al. (2001) Silent myocardial ischemia in patients with proved coronary artery disease: a comparison of diabetic and non-diabetic patients. Postgrad Med J 77: 395-398.
11. Domanski MJ, Borkow CB, Campeau L, Knatterud GL, White C, et al. (2000) Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators. J Am Coll Cardiol 36: 1877-1883.
12. Hassantash SA, Bikdeli B, Kalantarian S, Sadeghian M, Afshar H, (2008) Pathophysiology of Aortocoronary Saphenous Vein Bypass Graft Disease. Asian Cardiovasc Thorac Ann 16: 331-336.
13. Mitra AK, Gangahar DM, Agrawal DK, (2006) Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol Cell Biol 84: 115-124.
14. Muto A, Model L, Ziegler K, Eghbalieh SD, Dardik A, (2010) Mechanisms of vein graft adaptation to the arterial circulation - Insights into the neointimal algorithm and management strategies. Circ J 74: 1501-1512.
15. Millette E, Rauch BH, Kenagy RD, Daum G, Clowes AW, (2006) Platelet-derived growth factor-BB transactivates the fibroblast growth factor receptor to induce proliferation in human smooth muscle cells. Trends Cardiovasc Med 16: 25-28.
16. Rauch BH, Millette E, Kenagy RD, Daum G, Fischer JW, et al. (2005) Syndecan-4 is required for thrombin-induced migration and proliferation in human vascular smooth muscle cells. J Biol Chem 280: 17507-17511.
17. Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, et al. (2004) Long-term patency of the saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: Results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol 44: 2149-2156.
18. Chung MK (2007) Correlation Coefficient. In: Salkin NJ, editor. Encyclopedia of Measurement and Statistics. London: Sage Publications. 189-201.
19. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, et al. (2012) Third Universal definition of myocardial infarction. Eur Heart J 33: 2551-2567.
20. Angelini GD, Passani SL, Breckenridge IM, Newby AC, (1987) Nature and pressure dependence of damage induced by distension of human saphenous vein coronary artery bypass grafts. Cardiovasc Res 21: 902-907.
21. Bourassa MG, Campeau L, Lespérance J, Solymoss BC, (1986) Atherosclerosis after coronary artery bypass surgery: results of recent studies and recommendations regarding prevention. Cardiology 73: 259-268.
22. Davies AH, (1995) Vein factors that affect the outcome of femorodistal bypass. Ann R Coll Surg Engl 77: 63-66.
23. Marin ML, Veith FJ, Panetta TF, Gordon RE, Wengerter KR, et al. (1993) Saphenous vein biopsy: a predictor of vein graft failure. J Vasc Surg 18: 407-414.
24. Hubbell MC, Semotiuk AJ, Thorpe RB, Adeoye OO, Butler SM, et al. (2012) Chronic hypoxia and VEGF differentially modulate abundance and organization of myosin heavy chain isoforms in fetal and adult ovine arteries. Am J Physiol Cell Physiol 303: C1090-C1103.
25. Toda T, Tsuda N, Takagi T, Nishimori I, Leszczynski D at al, (1980) Ultrastructure of developing human ductus arteriosus. J Anat 131: 25-37.
26. Cambell JH, Cambell GR, (2012) Smooth Muscle Phenotypic Modulation - A Personal Experience. Arterioscler Thromb Vasc Biol 32: 1784-1789.
27. Hao H, Gabbiani G, Bochaton-Piallat ML, (2003) Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 23: 1510-1520.
28. Wang Z, Rao PJ, Castresana MR, Newman WH, (2005) TNF- induces proliferation or apoptosis in human saphenous vein smooth muscle cells depending on phenotype. Am J Physiol Heart Circ Physiol 288: 293-301.
29. Thakar RG, Cheng Q, Patel S, Chu J, Nasir M, et al. (2009) Cell-shape regulation of smooth muscle cell proliferation. Biophys J 96: 3423-3432.
30. Li S, Fan YS, Chow LH, Van Den Diepstraten C, van Der Veer E, et al. (2001) Innate diversity of adult human arterial smooth muscle cells: cloning of distinct subtypes from the internal thoracic artery. Circ Res 89: 517-525.
31. Bascands JL, Girolami JP, Troly M, Escargueil-Blanc I, Nazzal D, et al. (2001) Angiotensin II induces phenotype-dependent apoptosis in vascular smooth muscle cells. Hypertension 38: 1294-1299.
32. Dimitrova KR, Hofmann DM, Geller CM, Dincheva G, Ko W, et al. (2012) Arterial grafts protect the native coronary vessels from atherosclerotic disease progression. Ann Thorac Surg 94: 475-481.
33. Sabik J, Blackstone E, Gullinov M, Smedira N, Lytle B (2006) Occurrence and risk factors for reintervention after coronary artery bypass grafting. Circulation 114(Suppl I): 454-460.